熱門資訊> 正文
心脏诊断下降1为30反向股票分割
2025-05-08 20:48
- Cardio Diagnostics (NASDAQ:CDIO) announced on Thursday, a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.
- The reverse stock split is part of the company’s plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
- As a result of the reverse stock split, every 30 shares of the company’s common stock issued and outstanding prior to the opening of trading on May 13, 2025, will be combined into one issued and outstanding share, with no change in the nominal par value per share of $0.00001.
- As a result of the reverse stock split, the number of shares of common stock outstanding will be reduced from approximately 52M shares to approximately 1.7M shares, and the number of authorized shares of common stock will remain at 300M shares.
- Cardio Diagnostics (NASDAQ:CDIO) shares were down more than 40% in pre-market trading.
More on Cardio Diagnostics Holdings, Inc.
- Seeking Alpha’s Quant Rating on Cardio Diagnostics Holdings, Inc.
- Historical earnings data for Cardio Diagnostics Holdings, Inc.
- Financial information for Cardio Diagnostics Holdings, Inc.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
